Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CTMX
CTMX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CTMX News
CytomX Therapeutics Secures $250 Million Offering Amid Analyst Optimism
Apr 12 2026
Yahoo Finance
CytomX Therapeutics Price Target Raised by Analysts
Mar 18 2026
stocktwits
CytomX Therapeutics Prices Public Offering
Mar 18 2026
Yahoo Finance
CytomX Launches $250 Million Public Offering
Mar 18 2026
seekingalpha
CytomX Announces Pricing of Public Offering
Mar 18 2026
NASDAQ.COM
CytomX Launches $250 Million Public Offering
Mar 17 2026
NASDAQ.COM
CytomX Launches $250 Million Stock Offering to Fund Cancer Drug Development
Mar 17 2026
stocktwits
CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data
Mar 16 2026
Fool
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
NASDAQ.COM
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
Yahoo Finance
CytomX Launches $250 Million Underwritten Public Offering
Mar 16 2026
seekingalpha
CytomX Reports Significant Progress in Phase 1 Study of Varseta-M
Mar 16 2026
Yahoo Finance
CytomX Therapeutics Q4 2025 Earnings Call Insights
Mar 16 2026
seekingalpha
CytomX Reports Positive Clinical Data for Varseta-M and 2025 Financial Results
Mar 16 2026
NASDAQ.COM
NASDAQ 100 Pre-Market Indicator Rises Significantly
Mar 16 2026
NASDAQ.COM
CytomX Reports Promising Early Results for Varseta-M in Late-Line Metastatic Colorectal Cancer
Mar 16 2026
stocktwits
Show More News
